Michael Mainelli was named president/CEO of Active Implants (AIC; Memphis, Tennessee). Mainelli previously was president of Stryker Spine and president of Stryker Japan. AIC makes polymer technology for hip and knee segments of the orthopedic market.

Bryan Olin was named VP of quality for Cyberonics (Houston). Olin previously was senior director of quality assurance for Zeltiq Aesthetics. Cyberonics specializes in neuromodulation technology.

• Thoratec (Pleasanton, California) reported the election of Paul LaViolette, the former COO of Boston Scientific, to its board. Thoratec makes therapies to address advanced-stage heart failure.

• Serica Technologies (Medford, Massachusetts) reported the appointment of two senior staff members to support the continued clinical development and commercialization of its products in orthopedic and sports medicine, and aesthetic and reconstructive plastic surgery. Paul Weitzel, MD, an orthopedic surgeon and assistant clinical professor at Tufts University School of Medicine, was named VP of medical affairs, orthopedics. Mona Haynes was named chief commercial officer. Haynes most recently was chief commercial officer at Targanta Therapeutics. Serica is a growth-stage medical device company focused on silk-based biomaterial platform technology for human tissue repair and regeneration.